Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (1127) 1127
science & technology (715) 715
life sciences & biomedicine (702) 702
male (571) 571
leukoencephalopathy, progressive multifocal - etiology (568) 568
female (482) 482
adult (425) 425
middle aged (378) 378
neurosciences & neurology (351) 351
magnetic resonance imaging (341) 341
progressive multifocal leukoencephalopathy (339) 339
clinical neurology (301) 301
leukoencephalopathy, progressive multifocal - diagnosis (288) 288
biological and medical sciences (261) 261
leukoencephalopathy, progressive multifocal - pathology (259) 259
medical sciences (259) 259
brain - pathology (248) 248
neurology (218) 218
neurosciences (200) 200
leukoencephalopathy (182) 182
aged (173) 173
infectious diseases (164) 164
leukoencephalopathy, progressive multifocal - complications (162) 162
jc virus (149) 149
abridged index medicus (136) 136
aids/hiv (134) 134
acquired immunodeficiency syndrome - complications (127) 127
leukoencephalopathy, progressive multifocal - virology (122) 122
multiple sclerosis (122) 122
leukoencephalopathy, progressive multifocal - drug therapy (115) 115
leukoencephalopathy, progressive multifocal (104) 104
tomography, x-ray computed (102) 102
hiv infections - complications (99) 99
natalizumab (99) 99
diagnosis, differential (97) 97
fatal outcome (97) 97
viral diseases (95) 95
animals (92) 92
immunology (92) 92
jc virus - isolation & purification (87) 87
human viral diseases (86) 86
risk factors (86) 86
leukoencephalopathy, progressive multifocal - immunology (85) 85
child (79) 79
hiv (73) 73
patients (73) 73
medicine & public health (72) 72
diagnosis (70) 70
immunosuppressive agents - adverse effects (70) 70
adolescent (69) 69
viruses (68) 68
biopsy (67) 67
leukoencephalopathy, progressive multifocal - diagnostic imaging (66) 66
aids (65) 65
general & internal medicine (65) 65
virology (63) 63
health aspects (62) 62
leukoencephalopathy, progressive multifocal - chemically induced (61) 61
medicine, general & internal (60) 60
oncology (60) 60
antibodies, monoclonal - adverse effects (59) 59
pathology (59) 59
care and treatment (58) 58
retrospective studies (58) 58
brain - diagnostic imaging (57) 57
immunocompromised host (57) 57
multiple sclerosis - drug therapy (56) 56
treatment outcome (56) 56
jc virus - genetics (54) 54
disease progression (53) 53
infections (53) 53
leukoencephalopathy, progressive multifocal - epidemiology (53) 53
nervous system (53) 53
child, preschool (52) 52
drug therapy (52) 52
virus diseases (51) 51
brain (50) 50
central nervous system (50) 50
human immunodeficiency virus--hiv (50) 50
surgery (49) 49
viral diseases of the nervous system (49) 49
hematology (48) 48
rituximab (47) 47
immunosuppressive agents - therapeutic use (46) 46
hiv infections - drug therapy (45) 45
leukoencephalopathy, progressive multifocal - microbiology (45) 45
polyomaviridae (45) 45
viral diseases of the lymphoid tissue and the blood. aids (45) 45
jc virus - immunology (44) 44
psychiatry (44) 44
leukoencephalopathy, progressive multifocal - physiopathology (43) 43
transplantation (43) 43
antibodies, monoclonal - therapeutic use (42) 42
jc virus - pathogenicity (42) 42
prognosis (42) 42
case studies (39) 39
biomedicine (37) 37
development and progression (37) 37
immunologic factors - adverse effects (37) 37
monoclonal antibodies (37) 37
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1112) 1112
French (47) 47
Japanese (40) 40
Spanish (39) 39
German (23) 23
Polish (7) 7
Italian (4) 4
Russian (4) 4
Czech (3) 3
Hungarian (3) 3
Portuguese (3) 3
Danish (2) 2
Dutch (2) 2
Chinese (1) 1
Hebrew (1) 1
Romanian (1) 1
Slovak (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy
by Cortese, Irene and Muranski, Pawel and Enose-Akahata, Yoshimi and Ha, Seung-Kwon and Smith, Bryan and Monaco, MariaChiara and Ryschkewitsch, Caroline and Major, Eugene O and Ohayon, Joan and Schindler, Matthew K and Beck, Erin and Reoma, Lauren B and Jacobson, Steve and Reich, Daniel S and Nath, Avindra
The New England journal of medicine, ISSN 0028-4793, 04/2019, Volume 380, Issue 17, pp. 1597 - 1605
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Immune Reconstitution Inflammatory Syndrome - etiology | Brain - diagnostic imaging | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | CD4-Positive T-Lymphocytes - physiology | Viral Load | Adult | Female | Leukoencephalopathy, Progressive Multifocal - immunology | Antibodies, Monoclonal, Humanized - therapeutic use | Down-Regulation | Leukoencephalopathy, Progressive Multifocal - drug therapy | Programmed Cell Death 1 Receptor - metabolism | Cerebrospinal Fluid - virology | CD8-Positive T-Lymphocytes - physiology | White Matter - pathology | Magnetic Resonance Imaging | White Matter - diagnostic imaging | JC Virus - isolation & purification | Lymphocyte Count | Aged | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Immunologic Factors - therapeutic use | Drug therapy | Leukoencephalopathy | Nuclear magnetic resonance--NMR | PD-1 protein | Laboratories | CD8 antigen | Body weight | Immune clearance | Infections | Cerebrospinal fluid | Progressive multifocal leukoencephalopathy | Disability | Pembrolizumab | Lymphocytes | Peripheral blood | Drug dosages | Movement disorders | Antigens | Immune response | Cytokines | Patients | Lymphoma | CD4 antigen | Immune checkpoint | Cell death | Apoptosis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Clinical outcomes of natalizumab-associated progressive multifocal leukoencephalopathy
by Vermersch, P and Kappos, L and Gold, R and Foley, J.F and Olsson, T and Cadavid, D and Bozic, C and Richman, S
Neurology, ISSN 0028-3878, 05/2011, Volume 76, Issue 20, pp. 1697 - 1704
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Predictive Value of Tests | Prognosis | Natalizumab | Humans | Middle Aged | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Antineoplastic Agents - therapeutic use | Cause of Death | Socioeconomic Factors | Antibodies, Monoclonal, Humanized | Karnofsky Performance Status | Anti-Inflammatory Agents - therapeutic use | Product Surveillance, Postmarketing | Adult | Female | Mitoxantrone - therapeutic use | Disability Evaluation | Treatment Outcome | Leukoencephalopathy, Progressive Multifocal - mortality | Multiple Sclerosis - complications | Magnetic Resonance Imaging | Survival Analysis | Leukoencephalopathy, Progressive Multifocal - etiology | Early Diagnosis | Multiple Sclerosis - drug therapy | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Progressive Multifocal Leukoencephalopathy Associated with Ruxolitinib
by Milojkovic, Dragana and Wathes, Rowan and Moule, Simon
The New England journal of medicine, ISSN 0028-4793, 07/2013, Volume 369, Issue 2, pp. 197 - 198
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Janus Kinases - antagonists & inhibitors | Primary Myelofibrosis - drug therapy | Primary Myelofibrosis - complications | Humans | Brain - pathology | Leukoencephalopathy, Progressive Multifocal - etiology | Male | Aged | Pyrazoles - adverse effects | Nuclear magnetic resonance--NMR | Myelofibrosis | Biopsy | Ataxia | Janus kinase | Leukoencephalopathy | Progressive multifocal leukoencephalopathy | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Progressive Multifocal Leukoencephalopathy after Natalizumab Monotherapy
by Lindå, Hans and von Heijne, Anders and Major, Eugene O and Ryschkewitsch, Caroline and Berg, Johan and Olsson, Tomas and Martin, Claes
The New England journal of medicine, ISSN 0028-4793, 09/2009, Volume 361, Issue 11, pp. 1081 - 1087
Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | General aspects | Infectious diseases | Viral diseases | Biological and medical sciences | Viral diseases of the nervous system | Medical sciences | Human viral diseases | Leukoencephalopathy, Progressive Multifocal - immunology | Immune Reconstitution Inflammatory Syndrome - etiology | JC Virus - immunology | Natalizumab | JC Virus - genetics | Humans | Antibodies, Monoclonal - adverse effects | Antibodies, Monoclonal - therapeutic use | Male | Integrin alpha4 - immunology | DNA, Viral - blood | Multiple Sclerosis - complications | Antibodies, Monoclonal, Humanized | Leukoencephalopathy, Progressive Multifocal - chemically induced | Magnetic Resonance Imaging | Polymerase Chain Reaction | Brain - pathology | Multiple Sclerosis - pathology | Adult | Multiple Sclerosis - drug therapy | Case studies | Multiple sclerosis | Care and treatment | Diagnosis | Leukoencephalopathy, Progressive multifocal | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Progressive multifocal leukoencephalopathy after treatment with nivolumab
by Martinot, Martin and Ahle, Guido and Petrosyan, Inesa and Martinez, Camille and Gorun, Dragos M and Mohseni-Zadeh, Mahsa and Fafi-Kremer, Samira and Tebacher-Alt, Martine
Emerging infectious diseases, ISSN 1080-6040, 08/2018, Volume 24, Issue 8, pp. 1594 - 1596
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Hodgkin Disease - diagnostic imaging | Hodgkin Disease - virology | Antineoplastic Agents, Immunological - administration & dosage | Hodgkin Disease - pathology | Humans | Middle Aged | Hydrocortisone - therapeutic use | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Hodgkin Disease - drug therapy | Female | Leukoencephalopathy, Progressive Multifocal - virology | Nivolumab - adverse effects | Magnetic Resonance Imaging | Antineoplastic Agents, Immunological - adverse effects | Viremia - pathology | Viremia - virology | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | JC Virus - isolation & purification | Leukoencephalopathy, Progressive Multifocal - etiology | Viremia - diagnostic imaging | Aged | Leukoencephalopathy, Progressive Multifocal - diagnostic imaging | Leukoencephalopathy, Progressive Multifocal - pathology | Programmed Cell Death 1 Receptor - immunology | Viremia - etiology | Programmed Cell Death 1 Receptor - genetics | Nivolumab - administration & dosage | Care and treatment | Immunotherapy | Leukoencephalopathy, Progressive multifocal | Monoclonal antibodies | Lymphomas | T cells | Health aspects | Apoptosis | Index Medicus | immune checkpoint inhibitor | viruses | nivolumab | HIV | progressive multifocal leukoencephalopathy | JC virus | encephalitis | AIDS and other retroviruses | meningtitis | Progressive Multifocal Leukoencephalopathy after Treatment with Nivolumab | Research Letter | meningtitis/encephalaitis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Progressive multifocal leukoencephalopathy in transplant recipients
by Mateen, Farrah J and Muralidharan, RajaNandini and Carone, Marco and van de Beek, Diederik and Harrison, Daniel M and Aksamit, Allen J and Gould, Mary S and Clifford, David B and Nath, Avina
Annals of neurology, ISSN 0364-5134, 2011, Volume 70, Issue 2, pp. 305 - 322
Neurosciences | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Neurology | Infectious diseases | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Humans | Middle Aged | Risk Factors | Transplants - adverse effects | Leukoencephalopathy, Progressive Multifocal - virology | Male | Survival Rate | Leukoencephalopathy, Progressive Multifocal - diagnosis | PubMed | Young Adult | JC Virus | Adolescent | Leukoencephalopathy, Progressive Multifocal - etiology | Adult | Female | Aged | Retrospective Studies | Cohort Studies | Confidence intervals | Bone marrow | Transplants & implants | Human immunodeficiency virus--HIV | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Progressive multifocal leukoencephalopathy in patients on immunomodulatory therapies
by Major, Eugene O
Annual review of medicine, ISSN 0066-4219, 02/2010, Volume 61, Issue 1, pp. 35 - 47
Cell tropism factors | Immune system dysfunction | Viral latency and reactivation | Demyelination | Biological therapies for autoimmune diseases | Immunomodulation | Virus Latency | Humans | Autoimmune Diseases - complications | Autoimmune Diseases - therapy | Leukoencephalopathy, Progressive Multifocal - etiology | JC Virus - physiology | Leukoencephalopathy, Progressive Multifocal - pathology | Autoimmune Diseases - pathology | Usage | Care and treatment | Immunotherapy | Leukoencephalopathy, Progressive multifocal | Monoclonal antibodies | Causes of | Diagnosis | Health aspects | Neurology | Viruses | Medical treatment | Brain diseases | Cell adhesion & migration | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases
by Clifford, David B, MD and DeLuca, Andrea, MD and Simpson, David M, MD and Arendt, Gabriele, MD and Giovannoni, Gavin, MBBCh and Nath, Avindra, MD
Lancet neurology, ISSN 1474-4422, 2010, Volume 9, Issue 4, pp. 438 - 446
Neurology | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Antibodies, Monoclonal, Humanized | Leukoencephalopathy, Progressive Multifocal - therapy | Natalizumab | Humans | Antibodies, Monoclonal - adverse effects | Leukoencephalopathy, Progressive Multifocal - etiology | Antibodies, Monoclonal - therapeutic use | Immunologic Factors - adverse effects | Leukoencephalopathy, Progressive Multifocal - diagnosis | Leukoencephalopathy, Progressive Multifocal - epidemiology | Immunologic Factors - therapeutic use | Multiple Sclerosis - drug therapy | Medical colleges | Multiple sclerosis | Care and treatment | Leukoencephalopathy, Progressive multifocal | Index Medicus | Cerebrospinal fluid
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study
by Frederik Neess Engsig and Ann-Brit Eg Hansen and Lars Haukali Omland and Gitte Kronborg and Jan Gerstoft and Alex Lund Laursen and Court Pedersen and Christian Backer Mogensen and Lars Nielsen and Niels Obel
The Journal of infectious diseases, ISSN 0022-1899, 1/2009, Volume 199, Issue 1, pp. 77 - 83
Polymerase chain reaction | HIV/AIDS | Highly active antiretroviral therapy | HIV infections | Neurologic manifestations | HIV | JC virus | Mortality | AIDS | Symptoms | Progressive multifocal leukoencephalopathy | Fundamental and applied biological sciences. Psychology | Miscellaneous | Infectious diseases | Microbiology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Viral diseases of the nervous system | Medical sciences | Human viral diseases | Virology | Demography | Leukoencephalopathy, Progressive Multifocal - prevention & control | Humans | Male | Incidence | Speech Disorders - etiology | Cognition Disorders - etiology | Female | Risk Factors | Treatment Outcome | CD4 Lymphocyte Count | Leukoencephalopathy, Progressive Multifocal - mortality | Antiretroviral Therapy, Highly Active | Seizures - epidemiology | Speech Disorders - epidemiology | HIV Infections - complications | Seizures - etiology | Survival Analysis | Denmark - epidemiology | HIV Infections - drug therapy | Vision Disorders - epidemiology | Cognition Disorders - epidemiology | Leukoencephalopathy, Progressive Multifocal - epidemiology | Cohort Studies | Vision Disorders - etiology | Development and progression | Research | Patient outcomes | Leukoencephalopathy, Progressive multifocal | Distribution | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Pathogenesis of progressive multifocal leukoencephalopathy and risks associated with treatments for multiple sclerosis: a decade of lessons learned
by Major, Eugene O and Yousry, Tarek A and Clifford, David B
Lancet neurology, ISSN 1474-4422, 05/2018, Volume 17, Issue 5, pp. 467 - 480
Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Science & Technology | Leukoencephalopathy, Progressive Multifocal - immunology | Leukoencephalopathy, Progressive Multifocal - chemically induced | Humans | Natalizumab - adverse effects | Leukoencephalopathy, Progressive Multifocal - etiology | Leukoencephalopathy, Progressive Multifocal - virology | Immunologic Factors - adverse effects | Multiple Sclerosis - drug therapy | Medical colleges | Medical research | Neurosciences | Multiple sclerosis | Medicine, Experimental | Disease susceptibility | Drug therapy | Molecular biology | Health aspects | Leukoencephalopathy | Brain | Disease | Immunomodulation | Pathogenesis | Central nervous system | Infections | Patients | Progressive multifocal leukoencephalopathy | Magnetic resonance imaging | Surveillance | Demyelination | Binding sites | Deoxyribonucleic acid--DNA | Immune system | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Progressive multifocal leukoencephalopathy and newer biological agents
by Berger, Joseph R
Drug safety, ISSN 0114-5916, 2010, Volume 33, Issue 11, pp. 969 - 983
Polyomavirus-infections | Natalizumab, adverse reactions | Monoclonal-antibodies, adverse reactions | Efalizumab, adverse reactions | Progressive-multifocal- leukoencephalopathy, pathogenesis | Progressive-multifocal-leukoencephalopathy, drug-induced | Demyelinating-disorders, drug-induced | Mycophenolate-mofetil, adverse reactions | Rituximab, adverse reactions | Pharmacology & Pharmacy | Public, Environmental & Occupational Health | Toxicology | Life Sciences & Biomedicine | Science & Technology | JC Virus - immunology | Humans | Immunosuppressive Agents - therapeutic use | Antibodies, Monoclonal - adverse effects | Leukoencephalopathy, Progressive Multifocal - drug therapy | Leukoencephalopathy, Progressive Multifocal - virology | Antibodies, Monoclonal - therapeutic use